Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Mar Drugs ; 19(1)2021 Jan 08.
Article in English | MEDLINE | ID: mdl-33430011

ABSTRACT

Okadaic acid (OA) and its main structural analogs dinophysistoxin-1 (DTX1) and dinophysistoxin-2 (DTX2) are marine lipophilic phycotoxins distributed worldwide that can be accumulated by edible shellfish and can cause diarrheic shellfish poisoning (DSP). In order to study their toxicokinetics, mice were treated with different doses of OA, DTX1, or DTX2 and signs of toxicity were recorded up to 24 h. Toxin distribution in the main organs from the gastrointestinal tract was assessed by liquid chromatography-mass spectrometry (LC/MS/MS) analysis. Our results indicate a dose-dependency in gastrointestinal absorption of these toxins. Twenty-four hours post-administration, the highest concentration of toxin was detected in the stomach and, in descending order, in the large intestine, small intestine, and liver. There was also a different toxicokinetic pathway between OA, DTX1, and DTX2. When the same toxin doses are compared, more OA than DTX1 is detected in the small intestine. OA and DTX1 showed similar concentrations in the stomach, liver, and large intestine tissues, but the amount of DTX2 is much lower in all these organs, providing information on DSP toxicokinetics for human safety assessment.


Subject(s)
Marine Toxins/pharmacokinetics , Shellfish Poisoning , Animals , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Female , Intestines , Marine Toxins/toxicity , Mass Spectrometry , Mice , Mice, Inbred C57BL , Okadaic Acid/analogs & derivatives , Okadaic Acid/pharmacokinetics , Shellfish/analysis , Stomach , Tissue Distribution , Toxicokinetics
2.
Food Chem Toxicol ; 101: 121-127, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28089692

ABSTRACT

Okadaic acid (OA), Dinophysistoxins (DTX1 and DTX2) and their acyl-derivatives (DTX3) are marine toxins responsible for the human diarrhetic shellfish poisoning. To date the amount of toxins ingested from consumption of shellfish has been considered equal to the amount of toxins available for uptake by the human body. The aim of this study is to assess the OA, DTX2 and DTX3 fractions released from raw and steamed mussels and cockles into the digestive fluids (bioaccessibility) using a static in vitro digestion model. Higher bioaccessibility was found in mussels (86 ± 4%) than in cockles (59 ± 9%). A significant reduction of ester derivatives of OA and an increase of OA were observed in the bioaccessible fraction of mussel samples, suggesting that DTX3 undergo conversion into their more toxic parent compounds during human digestion. However, similar increase of DTX2 and reduction of the respective acyl derivatives was not observed. Steaming lead to significant reduction of OA and analogues bioaccessibility in both species even though increased concentrations of toxins are obtained after this treatment. Risk assessment based solely on DSP toxins occurrence in seafood can conduct to an overestimation of the exposure and lead to more conservative regulatory measures.


Subject(s)
Bivalvia/drug effects , Marine Toxins/pharmacokinetics , Okadaic Acid/pharmacokinetics , Pyrans/pharmacokinetics , Shellfish/analysis , Steam , Animals , Carcinogens/pharmacokinetics , Chromatography, Liquid/methods , Esters/chemistry , Fatty Acids/chemistry , Humans , In Vitro Techniques , Mass Spectrometry/methods
3.
Food Chem Toxicol ; 89: 54-9, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26783635

ABSTRACT

Okadaic acid (OA) and their derivatives are marine toxins responsible for the human diarrhetic shellfish poisoning (DSP). To date the amount of toxins ingested in food has been considered equal to the amount of toxins available for uptake by the human body. In this study, the OA fraction released from the food matrix into the digestive fluids (bioaccessibility) was assessed using a static in vitro digestion model. Naturally contaminated mussels (Mytilus galloprovincialis) and donax clams (Donax sp.), collected from the Portuguese coast, containing OA and dinophysistoxin-3 (DTX3) were used in this study. Bioaccessibility of OA total content was 88% and 75% in mussels and donax clams, respectively. Conversion of DTX3 into its parent compound was verified during the simulated digestive process and no degradation of these toxins was found during the process. This is the first study assessing the bioaccessibility of OA-group toxins in naturally contaminated seafood. This study provides relevant new data that can improve and lead to more accurate food safety risk assessment studies concerning these toxins.


Subject(s)
Marine Toxins/pharmacokinetics , Okadaic Acid/pharmacokinetics , Shellfish/analysis , Animals , Biological Availability , Chromatography, Liquid , In Vitro Techniques , Tandem Mass Spectrometry
4.
Toxins (Basel) ; 6(1): 211-28, 2014 Jan 03.
Article in English | MEDLINE | ID: mdl-24394641

ABSTRACT

Okadaic acid (OA) and its analogues, dinophysistoxin 1 (DTX1) and dinophysistoxin 2 (DTX2), are lipophilic and heat-stable marine toxins produced by dinoflagellates, which can accumulate in filter-feeding bivalves. These toxins cause diarrheic shellfish poisoning (DSP) in humans shortly after the ingestion of contaminated seafood. Studies carried out in mice indicated that DSP poisonous are toxic towards experimental animals with a lethal oral dose 2-10 times higher than the intraperitoneal (i.p.) lethal dose. The focus of this work was to study the absorption of OA, DTX1 and DTX2 through the human gut barrier using differentiated Caco-2 cells. Furthermore, we compared cytotoxicity parameters. Our data revealed that cellular viability was not compromised by toxin concentrations up to 1 µM for 72 h. Okadaic acid and DTX2 induced no significant damage; nevertheless, DTX1 was able to disrupt the integrity of Caco-2 monolayers at concentrations above 50 nM. In addition, confocal microscopy imaging confirmed that the tight-junction protein, occludin, was affected by DTX1. Permeability assays revealed that only DTX1 was able to significantly cross the intestinal epithelium at concentrations above 100 nM. These data suggest a higher oral toxicity of DTX1 compared to OA and DTX2.


Subject(s)
Marine Toxins/toxicity , Okadaic Acid/toxicity , Pyrans/toxicity , Caco-2 Cells , Humans , Intestinal Absorption/drug effects , Lethal Dose 50 , Marine Toxins/pharmacokinetics , Microscopy, Confocal , Okadaic Acid/analogs & derivatives , Okadaic Acid/pharmacokinetics , Pyrans/pharmacokinetics
5.
Toxicol Lett ; 225(2): 311-7, 2014 Mar 03.
Article in English | MEDLINE | ID: mdl-24374049

ABSTRACT

The consumption of okadaic acid (OA) contaminated shellfish can induce acute toxic symptoms in humans such as diarrhea, nausea, vomiting and abdominal pain; carcinogenic and embryotoxic effects have also been described. Toxicokinetic studies with mice have shown that high cytotoxic doses of OA can pass the gastrointestinal barrier presumably by paracellular passage. However, in vitro studies using human intestinal Caco-2 cell monolayers to represent the intestinal barrier have shown that at low-dose exposure OA is transported against a concentration gradient suggesting an active efflux mechanism. Since P-glycoprotein (P-gp) transports a wide variety of substrates, we investigated its possible influence on the observed elimination of OA. We used two different cellular transwell models: (i) Caco-2 cell monolayer endogenously expressing human P-gp and simulating the intestinal barrier and (ii) MDCK-II cell monolayer stably over-expressing P-gp. Our study demonstrates clearly that OA at non-cytotoxic concentrations passes the monolayer barrier only to a low degree, and that it is actively eliminated by P-gp over the apical membrane. Therefore, our in vitro data indicate that humans appear to have efficient defense mechanisms to protect themselves against low-dose contaminated shellfish by exhibiting a low bioavailability as a result of active elimination of OA by P-gp.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Carcinogens/pharmacokinetics , Intestines/drug effects , Okadaic Acid/pharmacokinetics , Animals , Biological Availability , Biological Transport , Caco-2 Cells , Carcinogens/toxicity , Chromatography, High Pressure Liquid , Dogs , Dose-Response Relationship, Drug , Humans , Inactivation, Metabolic , Intestinal Mucosa/metabolism , Madin Darby Canine Kidney Cells , Marine Toxins/pharmacokinetics , Marine Toxins/toxicity , Mice , Mitochondria/drug effects , Mitochondria/metabolism , Okadaic Acid/toxicity , Solid Phase Extraction , Tandem Mass Spectrometry
6.
Toxins (Basel) ; 5(11): 2093-108, 2013 Nov 08.
Article in English | MEDLINE | ID: mdl-24217398

ABSTRACT

In vivo, after administration by gavage to mice and rats, okadaic acid has been reported to produce lesions in liver, small intestine and forestomach. Because several reports differ in the damage detected in different organs, and on okadaic acid distribution after consumption, we determined the toxicity of this compound after oral administration to mice. After 24 hours, histopathological examination showed necrotic foci and lipid vacuoles in the livers of intoxicated animals. By immunohistochemical analysis, we detected this toxin in the liver and kidneys of intoxicated animals. Okadaic acid induces oxidative stress and can be activated in vitro into reactive compounds by the post-mitochondrial S9 fraction, so we studied the okadaic effect on the gene expression of antioxidant and phase II detoxifying enzymes in liver. We observed a downregulation in the expression of these enzymes and a reduction of protein expression of catalase and superoxide dismutase 1 in intoxicated animals.


Subject(s)
Liver/pathology , Okadaic Acid/pharmacokinetics , Okadaic Acid/toxicity , Oxidative Stress/drug effects , Administration, Oral , Animals , Antioxidants/pharmacology , Diarrhea/chemically induced , Feces/chemistry , Female , Gene Expression , Immunohistochemistry , Inactivation, Metabolic , Intestine, Small/drug effects , Intestine, Small/pathology , Kidney/drug effects , Kidney/pathology , Liver/drug effects , Mice , Okadaic Acid/blood , Stomach/drug effects , Stomach/pathology
7.
Toxicology ; 279(1-3): 196-202, 2011 Jan 11.
Article in English | MEDLINE | ID: mdl-21093526

ABSTRACT

The marine biotoxin okadaic acid (OA), produced by dinoflagellates, can accumulate in various bivalve molluscs. In humans, oral consumption of shellfish contaminated with OA induces acute toxic effects like diarrhea, nausea, vomiting and abdominal pain. However, tumorigenic and embryotoxic effects of OA have been also described. Current toxicokinetic studies with mice were performed with high cytotoxic oral doses leading presumably to a paracellular passage of OA through the gastrointestinal barrier. There are no studies available analyzing the absorption at low concentrations, which represent a realistic dietary exposure, making a reliable risk assessment difficult. Therefore, we performed a low-dose study using the human intestinal Caco-2 cell model to simulate the intestinal barrier. Low level exposure of 20-200 nM OA to the cell monolayer allows an only limited passage from the "luminal" to the "blood side". Furthermore, we could detect a significant efflux of OA, which led to the suggestion that active transport mechanisms are involved in the elimination process of OA. In conclusion, our results indicate that besides the well known defense mechanisms of humans against this marine biotoxin--vomiting and diarrhea--further detoxification mechanisms are available to limit the absorption of toxic OA.


Subject(s)
Intestinal Absorption , Marine Toxins/pharmacokinetics , Okadaic Acid/pharmacokinetics , Biological Availability , Biological Transport, Active , Caco-2 Cells , Dose-Response Relationship, Drug , Humans , Marine Toxins/administration & dosage , Okadaic Acid/administration & dosage , Tissue Distribution
8.
Toxicon ; 51(6): 1081-9, 2008 May.
Article in English | MEDLINE | ID: mdl-18342356

ABSTRACT

Using high-performance liquid chromatography with mass spectrometry, the influence of conventional steaming and another heat treatment on the level of okadaic acid and dinophysistoxin-2 in mussels (Mytilus edulis) was investigated. Concentration increases correlated with water loss during steaming, and increased distribution of okadaic acid and dinophysistoxin-2 from the digestive glands to the remainder tissues was observed as a result of the processes examined. This suggests that the analysis of whole flesh tissues, as opposed to dissected digestive glands, is more appropriate for regulatory purposes, particularly if cooked samples are being analysed. A systematic heat treatment experiment showed that while okadaic acid group toxins are stable during cooking processes, degradation does occur in mussel tissues after prolonged exposure to high temperatures. The findings of the studies reported here have importance in terms of the methodology applied in regulatory phycotoxin monitoring programmes. Therefore, options for sample pretreatment are discussed.


Subject(s)
Cooking , Hot Temperature , Marine Toxins/pharmacokinetics , Mytilus edulis/metabolism , Okadaic Acid/pharmacokinetics , Pyrans/pharmacokinetics , Animals , Chromatography, High Pressure Liquid , Digestive System/metabolism , Mass Spectrometry , Time Factors , Tissue Distribution
9.
Environ Toxicol ; 21(1): 55-64, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16463260

ABSTRACT

Micronucleus induction by the diarrhetic shellfish toxin okadaic acid (OA) was investigated in two intestinal models, cultured human Caco-2 cells and colon epithelial cells of mice treated in vivo. Exposure to OA for 4 and 24 h induced dose-responsive increases in the frequency of micronucleated Caco-2 cells; the minimum OA doses increasing micronucleus frequency were 20 nM for the 4 h treatment and 5 nM for the 24 h treatment. OA treatment of Caco-2 cells also resulted in dose- and time-dependent increases in mitotic arrest and multinucleated cells. Two experiments were conducted in which mice were treated with single oral gavages of 435-610 and 115-1341 microg/kg OA. In the first experiment, samples were taken 24 h after the treatment, and the frequencies of both micronucleated and mitotic gut cells were increased after treatment with 525 microg/kg OA. In the second experiment, no increases in micronucleus frequency were detected at 24, 36, or 48 h following OA doses of 230 and 115 microg/kg; however, an increase in the mitotic index was observed 36 h after a gavage with 115 microg/kg OA. In this experiment, doses higher than 230 microg/kg were rapidly lethal to the mice. Immunohistology with monoclonal OA antibodies showed that OA was distributed into the liver at all the sampling times and in the small intestine at 24 and 36 h; OA was not detected in the colon. In addition, the TUNEL assay indicated that OA induced apoptosis in mouse ileum, liver, and kidney. The results of our investigations suggest that OA is aneugenic in Caco-2 cells, whereas the in vivo data were inconclusive. Further studies should be performed in mice using intragastric doses of 230-525 microg/kg OA. Moreover, the apoptosis and cell proliferation results indicate that OA can reach organs other than colon, indicating further evaluation of the genotoxic potential of OA in these organs is warranted.


Subject(s)
Aneugens/toxicity , Marine Toxins/toxicity , Okadaic Acid/toxicity , Animals , Apoptosis/drug effects , Caco-2 Cells , Colon/drug effects , Colon/metabolism , Duodenum/drug effects , Duodenum/metabolism , Female , Food Contamination , Humans , Ileum/drug effects , Ileum/metabolism , In Situ Nick-End Labeling , Kidney/drug effects , Liver/drug effects , Liver/metabolism , Marine Toxins/pharmacokinetics , Mice , Micronuclei, Chromosome-Defective/chemically induced , Micronucleus Tests , Mitosis/drug effects , Okadaic Acid/pharmacokinetics
10.
Toxicon ; 44(2): 123-34, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15246759

ABSTRACT

Different toxin profiles of dinophysistoxins and pectenotoxins have been reported before between blue mussel and other bivalve species, such as common cockle, razor clam, clams, etc. Comparison of toxins present in plankton in mussel growing areas and in cockle growing areas, respectively, showed there was no particular incidence of dinophysistoxin-2 (DTX2) in plankton from mussel growing areas that could account for the higher percentage of DTX2 in relation to okadaic acid (OA) found in mussels; or of pectenotoxin-2 in cockle growing areas that could explain the higher levels of pectenotoxin-2 seco acid (PTX2sa) found in cockles. A detoxification experiment between mussels and cockles showed the higher percentage of DTX2 in mussels was due to slower elimination of this toxin in relation to OA; while the lower levels of PTX2sa were due to quicker elimination by mussels than by cockles. The slower elimination of DTX2 explains why in late summer and autumn this toxin gradually accumulate in mussels throughout the entire coast, while other bivalves species have a lower percentage of DTX2, very close to the 3:2 OA:DTX2 ratio found in natural plankton assemblages when Dinophysis acuta predominates. In the clam Donax spp., DTX2 concentration also tends to build up in relation to OA, this being made up predominantly by free DTX2 while esterified DTX2 is found only in trace levels (similarly to what is found in mussel for DTX2). We hypothesise that the esterified forms of OA and DTX2 are more easily eliminated than the free forms, by all shellfish species. The free forms are more difficult to eliminate. This is particularly notable in these two species that present a very low conversion of DTX2 into acyl esters. The high pool of free toxins is partially responsible for these two species (mussel and Donax clams) being the sentinel species for DSP contamination throughout the Portuguese coast. Esters of OA and DTX2 were found in a plankton sample where D. acuta was the predominant toxic species found. The nature of the esters remains to be elucidated. The boiling of these DTX2 esters seems to favour the rearrangement of the parent molecule to the DTX2 isomer, DTX2i, recoverable after alkaline hydrolysis. The isomerization was also observed with DTX2 esters present in mussel, but thus not appear to occur with the same extent with free DTX2.


Subject(s)
Furans/pharmacokinetics , Marine Toxins/pharmacokinetics , Mollusca/metabolism , Okadaic Acid/pharmacokinetics , Pyrans/pharmacokinetics , Animals , Bivalvia/metabolism , Decontamination/methods , Digestive System/metabolism , Digestive System/pathology , Dinoflagellida , Environmental Monitoring , Esterification , Macrolides , Organ Size , Species Specificity
11.
Environ Toxicol ; 19(2): 123-8, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15037998

ABSTRACT

Okadaic acid (OA), a major polyether toxin involved in diarrhetic shellfish poisoning (DSP), is a potent tumor promoter in rodent skin and glandular stomach and a specific inhibitor of the serine/threonine protein phosphatases PP1 and PP2A. A previous study, which used the cytokinesis-block micronucleus (CBMN) assay in CHO-K1 cells, showed that OA induced chromosome damage in the presence of a rat liver metabolic activation system (S9). To support OA biotransformation by S9, the same test system was performed, and DNA damage induced by OA was measured with and without metabolic activation as well as in the presence of heat-inactivated S9 fraction. The results showed that only in the presence of active S9 did OA significantly increased the frequency of micronucleated binucleated (MNBN) cells. After a 4-h treatment a 2- to 5-fold increase of MNBN cells was observed at 30 nM and at 50 nM of OA. However, without S9 or in the presence of heat-inactivated S9, OA did not induce any chromosome damage. We concluded that OA can be metabolically activated in vitro into metabolites that are more genotoxic. The CBMN assay coupled with fluorescence in situ hybridization (FISH) using a DNA probe for centromere detection was performed to discriminate between clastogenic (chromosome breakage) and aneugenic (chromosome loss) effects. FISH analysis showed that OA metabolites increased in a dose-dependent manner in centromere positive micronuclei (CEN+): 60% of CEN+ at 30 nM and 75% of CEN+ at 50 nM of OA. The uptake of OA into CHO-K1 cells and the biotransformation of the toxin are discussed.


Subject(s)
Aneuploidy , DNA Damage/drug effects , Micronuclei, Chromosome-Defective/drug effects , Okadaic Acid/toxicity , Analysis of Variance , Animals , CHO Cells , Cell Division/drug effects , Chromosome Breakage , Chromosome Deletion , Cricetinae , Cricetulus , Dose-Response Relationship, Drug , In Situ Hybridization, Fluorescence , Liver/chemistry , Micronucleus Tests , Okadaic Acid/pharmacokinetics , Rats , Rats, Sprague-Dawley
12.
Aquat Toxicol ; 62(4): 269-80, 2003 Feb 26.
Article in English | MEDLINE | ID: mdl-12595167

ABSTRACT

The time course of several outbreaks of the diarrhetic shellfish poisoning (DSP) producer Dinophysis acuminata and the consequent kinetic of accumulation and loss of toxins in mussels Mytilus galloprovincialis feeding on them was studied. Samples of mussels and seawater were frequently (2-3 times a week) collected from a raft in the Ri;a de Vigo. DSP toxins content of mussels and water was analyzed by HPLC-FD and phytoplankton was quantified in an inverted light microscope. Only okadaic acid (OA) and some of its conjugated forms (OA CF), estimated by enzymatic hydrolysis, were found in the plankton samples obtained, comprised mainly of D. acuminata cells. The main accumulated form in mussels was OA reaching a maximum of 10.1 microg OA g(-1) in the digestive gland (d.g.) in 16 days, falling below the quarantine level (ca. 2 microg OA g(-1) d.g.) by 45 days. The low polarity conjugated forms (LPCF), estimated by hexane extraction, accounted for 6.2% of the total toxin burden of the mussels. To quantify the rates of the processes involved in the accumulation, transformation and loss of the toxins, two dynamic models, a one-compartment and a two-compartment, including OA and its conjugated forms as variables were designed and implemented. The one-compartment model provided a good fit to the OA and LPCF actual data (r(2)=0.92 and r(2)=0.94, respectively). The two-compartment model did not fit the data markedly better than its one-compartment counterpart (r(2)=0.93 and r(2)=0.95, for OA and LPCF, respectively). High hydrolysis rates were estimated for most of the OA CF, which means that these forms came largely from the ingested plankton. The low estimated acylation rates support the previous point and suggest that the formation of LPCF by direct acylation of the OA is of little importance in M. galloprovincialis. Only in cases where the intoxication period is very long, can the formed acyl-derivatives be important, because they seem to accumulate for a long time in the mussels, as suggested by the low hydrolysis and depuration rates estimated from model fitting.


Subject(s)
Bivalvia , Dinoflagellida/chemistry , Marine Toxins/metabolism , Okadaic Acid/metabolism , Animals , Hydrolysis , Marine Toxins/pharmacokinetics , Okadaic Acid/pharmacokinetics , Tissue Distribution
13.
Toxicon ; 40(2): 159-65, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11689237

ABSTRACT

This paper describes the distribution and excretion of okadaic acid (OA) administered orally to mice and examined by immunostaining method. Five min after administration, OA was systemically distributed, being detected in the lung, liver, heart, kidney, and small and large intestine. The swollen small intestinal villi contained OA, causing the separation of epithelial cells from villi and erosion, which developed within 1h. Bleeding and edema in the lung were also found, and the distribution of OA coincided with these injuries. Although a considerable amount of OA was accumulated in the liver, no symptoms, such as bleeding, were observed. The detection of OA continued for 2 weeks in the liver and blood vessels. Excretion from kidney, cecum and large intestine began even after 5 min of the administration, and the excretion from intestine continued for 4 weeks.


Subject(s)
Carcinogens/pharmacokinetics , Marine Toxins/pharmacokinetics , Okadaic Acid/pharmacokinetics , Administration, Oral , Animals , Carcinogens/administration & dosage , Gastric Mucosa/metabolism , Immunohistochemistry , Injections, Spinal , Intestinal Mucosa/metabolism , Intestines/pathology , Kidney/metabolism , Kidney/pathology , Liver/metabolism , Liver/pathology , Male , Marine Toxins/administration & dosage , Mice , Mice, Inbred ICR , Microcystins , Okadaic Acid/administration & dosage , Organ Size , Peptides, Cyclic/administration & dosage , Peptides, Cyclic/pharmacokinetics , Stomach/pathology , Tissue Distribution
14.
Hum Exp Toxicol ; 18(5): 345-50, 1999 May.
Article in English | MEDLINE | ID: mdl-10372758

ABSTRACT

Okadaic acid (OA) is the main toxin produced by dinoflagellates which can accumulate in the hepatopancreas of mussels and cause diarrhetic shellfish poisoning in consumers. This toxin is also a tumour promoter and a specific potent inhibitor of protein phosphatases 1 and 2A. No specific target organ is known for this toxin. This study concerns the distribution of [3H]OA in organs and biological fluids of Swiss mice having received a single dose per os of AO (50 microg/kg). The determination of the toxin extracted from mouse organs 24 h after administration of [3H]OA and derivatised with 9-anthryldiazomethane (ADAM) before HPLC and fluorescent detection showed the highest concentration in intestinal tissue and stomach. This distribution was even more pronounced in intestinal tissue, when animal were given per os 90 microg/kg which induced diarrhoea. The high concentrations of [3H]OA in intestinal tissues and contents 24 h after administration demonstrates a slow elimination of OA. When the dose of OA was increased from 50-90 microg/kg, the concentrations of the toxin in the intestinal content and faeces increased proportionally. A good correlation was found between an increase of OA in the intestinal tissue and the diarrhoea in animals given 90 microg/kg orally. Moreover OA was present in liver and bile and in all organs including skin and also fluids. Altogether these results confirmed an enterohepatic circulation of OA as previously shown. These data also revealed that in acute OA intoxication the concentration of the toxin in the intestinal tissues reaches cytotoxic concentrations in accordance with the diarrhoea which is the main symptom of OA poisoning.


Subject(s)
Carcinogens/pharmacokinetics , Diarrhea/metabolism , Okadaic Acid/pharmacokinetics , Animals , Body Fluids/metabolism , Carcinogens/toxicity , Diarrhea/chemically induced , Enzyme Inhibitors/pharmacokinetics , Enzyme Inhibitors/toxicity , Mice , Okadaic Acid/toxicity , Tissue Distribution
15.
Toxicon ; 35(6): 843-7, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9241779

ABSTRACT

Okadaic acid, a macrocyclic polyether compound, was shown to mediate the transfer of Na+, K+, Mg2+ and Ca2+ ions from aqueous solution to an organic phase, with a preference for Na+ ions. A kinetic study of the transport of these ions across a liquid membrane showed that the Na+ ion was more rapidly transported than the other ions and that the Na+ ion flux was dependent on the okadaic acid concentration.


Subject(s)
Cations/pharmacokinetics , Chloroform , Marine Toxins/pharmacokinetics , Membranes, Artificial , Okadaic Acid/pharmacokinetics , Biological Transport/physiology , Calcium/pharmacokinetics , Cations/chemistry , Magnesium/pharmacokinetics , Marine Toxins/chemistry , Okadaic Acid/chemistry , Picrates , Potassium/pharmacokinetics , Sodium/pharmacokinetics
16.
Plant Physiol ; 113(4): 1273-82, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9112776

ABSTRACT

We investigated the signaling pathways that control changes in plastid transcription in response to development and light. Plastid gene expression was analyzed in dark-grown barley (Hordeum vulgare L.) seedlings treated in vivo with an inhibitor of protein phosphatases 1 and 2A, okadaic acid (OA), or an inhibitor of protein kinases (K252a), followed by exposure of the seedlings to either red, blue, or white light. OA prevented blue light from activating the plastid pshD blue-light-responsive promoter (BLRP) and prevented red and blue light from activating the expression of the plastid-encoded rbcl and psbA and the nuclear-encoded RbcS and Lhcb genes. OA reduced total plastid transcription activity in dark- and light-grown seedlings by 77 to 80%, indicating that OA prevented light-responsive transcription by reducing total plastid transcription. In contrast, K252a activated the accumulation of mRNAs arising from the BLRP. Blue light in combination with K252a increased psbD mRNA levels in an additive manner. The results indicate that protein phosphatases 1 and/or 2A, which reside external to the organelle, are required for proper function of plastid transcription and chloroplast development, whereas a protein kinase represses the BLRP in plants grown in the dark.


Subject(s)
Hordeum/physiology , Phosphoprotein Phosphatases/metabolism , Photosynthetic Reaction Center Complex Proteins/biosynthesis , Photosynthetic Reaction Center Complex Proteins/genetics , Plastids/metabolism , Promoter Regions, Genetic , Protein Kinases/metabolism , Transcription, Genetic , Carbazoles/pharmacokinetics , Carbazoles/pharmacology , DNA Primers , Darkness , Enzyme Inhibitors/pharmacology , Hordeum/genetics , Indole Alkaloids , Light , Models, Biological , Okadaic Acid/pharmacokinetics , Okadaic Acid/pharmacology , Photosystem II Protein Complex , RNA, Messenger/biosynthesis , Signal Transduction , Transcription, Genetic/drug effects
17.
Hum Exp Toxicol ; 15(3): 226-30, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8839210

ABSTRACT

Okadaic acid (OA) is the main toxin produced by dinoflagellates, which can accumulate in the hepatopancreas of mussels and cause diarrhoetic shellfish poisoning in consumers. This toxin is also a tumour promoter and a specific potent inhibitor of protein phosphatases 1 and 2A. The results in this study show for the first time that this marine toxin is able to cross the transplacental barrier. Foetal tissue contains more okadaic acid than the liver or kidney: 5.60% compared to 1.90 and 2.55% respectively as measured by HPLC and fluorescent detection after derivatization with 9-Anthryldiazomethane (ADAM). In view of its adverse effects, okadaic acid might impair foetal development and promote tumours in neonates.


Subject(s)
Chromatography, High Pressure Liquid , Maternal-Fetal Exchange , Okadaic Acid/pharmacokinetics , Scintillation Counting , Animals , Anthracenes , Female , Fluorescent Dyes , Mice , Pregnancy , Tritium
18.
Am J Physiol ; 270(2 Pt 1): C449-56, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8779906

ABSTRACT

The rates of transport of the protein phosphatase inhibitors okadaic acid and calyculin A through rabbit erythrocyte membranes have been estimated by measuring protein phosphatase type 2A (PP2A) activity in lysates. High concentrations of okadaic acid (100 nM) cause rapid (t 1/2 approximately 10 min) inhibition of PP2A. However, the t 1/2 for okadaic acid influx is much longer because the concentration is much higher than the concentration inhibiting 50% of the maximal response (IC50). The estimated t 1/2 is over 1 h at 37 degrees C and over 4 h at 25 degrees C. The effect of low extracellular pH indicates that the undissociated acid is the permeant species. It takes hours to reverse the effect of okadaic acid, because the efflux must proceed through several half times before the concentration is below the IC50 for PP2A. The permeation of calyculin A in contrast to okadaic acid is too fast to measure at 25 degrees C. Our results indicate that okadaic acid entry into erythrocytes is slower than is generally believed; it is crucial to consider concentration, temperature, pH, and time of exposure to okadaic acid to interpret the effects of this agent on intact cells.


Subject(s)
Erythrocyte Membrane/metabolism , Okadaic Acid/pharmacokinetics , Oxazoles/pharmacokinetics , Animals , Cell Membrane Permeability , Dose-Response Relationship, Drug , Marine Toxins , Osmolar Concentration , Phosphoprotein Phosphatases/antagonists & inhibitors , Rabbits/blood , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...